0001613103-20-000024.txt : 20200824 0001613103-20-000024.hdr.sgml : 20200824 20200824070323 ACCESSION NUMBER: 0001613103-20-000024 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 16 CONFORMED PERIOD OF REPORT: 20200821 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20200824 DATE AS OF CHANGE: 20200824 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Medtronic plc CENTRAL INDEX KEY: 0001613103 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 000000000 FISCAL YEAR END: 0424 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36820 FILM NUMBER: 201124669 BUSINESS ADDRESS: STREET 1: 20 ON HATCH, LOWER HATCH STREET CITY: DUBLIN STATE: L2 ZIP: 2 BUSINESS PHONE: 01135314381700 MAIL ADDRESS: STREET 1: 20 ON HATCH, LOWER HATCH STREET CITY: DUBLIN STATE: L2 ZIP: 2 FORMER COMPANY: FORMER CONFORMED NAME: Medtronic Ltd DATE OF NAME CHANGE: 20150112 FORMER COMPANY: FORMER CONFORMED NAME: Medtronic Holdings Ltd DATE OF NAME CHANGE: 20140711 FORMER COMPANY: FORMER CONFORMED NAME: Kalani I Ltd DATE OF NAME CHANGE: 20140709 8-K 1 mdt-20200821.htm 8-K mdt-20200821
0001613103Medtronic plcD02 XH02false00016131032020-08-212020-08-210001613103us-gaap:CommonStockMember2020-08-212020-08-210001613103mdt:SeniorNotes2019Due2021FloatingMember2020-08-212020-08-210001613103mdt:SeniorNotes2019Due2021Member2020-08-212020-08-210001613103mdt:SeniorNotes2019Due2022Member2020-08-212020-08-210001613103mdt:SeniorNotes2019Due20230.375PercentMember2020-08-212020-08-210001613103mdt:SeniorNotes2019Due2025Member2020-08-212020-08-210001613103mdt:SeniorNotes2019Due2027Member2020-08-212020-08-210001613103mdt:SeniorNotes2019Due20311.625PercentMember2020-08-212020-08-210001613103mdt:SeniorNotes2019Due20311.00PercentMember2020-08-212020-08-210001613103mdt:SeniorNotes2019Due20392.250PercentMember2020-08-212020-08-210001613103mdt:SeniorNotes2019Due20391.50PercentMember2020-08-212020-08-210001613103mdt:SeniorNotes2019Due2049Member2020-08-212020-08-21

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
_____________________________ 
FORM 8-K
 _____________________________ 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 21, 2020
 _____________________________ 
Medtronic Public Limited Company
(Exact name of Registrant as Specified in its Charter)
  _____________________________ 
 
Ireland 1-36820 98-1183488
(State or other jurisdiction
of incorporation)
 
(Commission
File Number)
 
(IRS Employer
Identification No.)

20 On Hatch, Lower Hatch Street
Dublin 2, Ireland
(Address of principal executive offices)
+353 1 438-1700
(Registrant’s telephone number, including area code)
Not Applicable
Former name or former address, if changed since last report
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))













Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading SymbolName of each exchange on which registered
Ordinary shares, par value $0.0001 per shareMDTNew York Stock Exchange
Floating Rate Notes due 2021MDT/21New York Stock Exchange
0.000% Senior Notes due 2021MDT/21ANew York Stock Exchange
0.000% Senior Notes due 2022MDT/22BNew York Stock Exchange
0.375% Senior Notes due 2023MDT/23BNew York Stock Exchange
0.25% Senior Notes due 2025MDT/25New York Stock Exchange
1.125% Senior Notes due 2027MDT/27New York Stock Exchange
1.625% Senior Notes due 2031MDT/31New York Stock Exchange
1.00% Senior Notes due 2031MDT/31ANew York Stock Exchange
2.250% Senior Notes due 2039MDT/39ANew York Stock Exchange
1.50% Senior Notes due 2039MDT/39BNew York Stock Exchange
1.75% Senior Notes due 2049MDT/49New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.






Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On August 21, 2020, the Board of Directors (the “Board”) of Medtronic plc (the “Company”) increased the size of the Board from 12 to 13 and appointed Kevin E. Lofton as a new director of the Company, in each case effective as of September 15, 2020. Mr. Lofton has been appointed to serve on the Audit, Compensation and Quality committees of the Board.

In connection with his appointment to the Board, pursuant to the Company’s non-employee director compensation policy, Mr. Lofton will be eligible to receive an annual cash retainer and a director equity grant, in each case as described under “Corporate Governance—Director Compensation” in the Company’s Definitive Proxy Statement on Schedule 14A filed with the SEC on August 14, 2020. The Company intends to file a revised Definitive Proxy Statement to include Mr. Lofton as a nominee for election to the Board by a vote of the Company’s shareholders at the Company’s 2020 Annual General Meeting.

There were no arrangements or understandings between Mr. Lofton and any other persons pursuant to which he was selected as a director, and neither Mr. Lofton nor any of his immediate family has been a party to any transaction or currently proposed transaction with the Company that is reportable under Item 404(a) of Regulation S-K.

A press release announcing Mr. Lofton’s appointment was issued on August 24, 2020. A copy of such press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference herein.
 
Item 9.01.
Financial Statements and Exhibits.

(d) List of Exhibits
Exhibit Number  Description
  
104
Cover Page Interactive Data File (embedded with the Inline XBRL document).








SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
   MEDTRONIC PUBLIC LIMITED COMPANY
Date: August 24, 2020   By /s/ Bradley E. Lerman
   Bradley E. Lerman
   
Senior Vice President, General Counsel and Corporate Secretary





EX-99.1 2 pressrelease8242020.htm EX-99.1 Document

image011.jpg

NEWS RELEASE
Contacts:

Erika WinkelsRyan Weispfenning
Public RelationsInvestor Relations
+1-763-526-8478+1-763-505-4626
FOR IMMEDIATE RELEASE

Medtronic Board Appoints Kevin Lofton as A New Director

DUBLIN – August 24, 2020 – Medtronic plc (NYSE:MDT) today announced that its Board of Directors appointed Kevin Lofton to the Board as an independent director, effective September 15, 2020. Mr. Lofton will serve on the following committees of the board: Audit, Compensation, and Quality.

“Kevin Lofton has made a broad impact across the healthcare industry and is a practiced and experienced board member,” said Omar Ishrak, executive chairman and chairman of the Board, Medtronic. “His experience leading healthcare provider organizations and ability to successfully navigate evolving commercial, regulatory and public policy changes over time will provide the Medtronic Board with valuable perspective and insights – we are glad to have him join us to help guide Medtronic into the future of healthcare.”

Mr. Lofton is a veteran healthcare executive, innovator and strategist. He has spent 25 years as the Chief Executive Officer of some of the largest hospital systems in the United States. Recently, he retired as Chief Executive Officer of CommonSpirit Health, previously serving as the Chief Executive Officer of Catholic Health Initiatives from 2003 until it merged with DignityHealth to form CommonSpirit in 2019.

Throughout his career, Mr. Lofton has had a broad impact across the healthcare landscape. He particularly focused on addressing disparities in healthcare and finding solutions to



eliminate them. He was the founding chair of the American Hospital Association’s (AHA) Equity of Care Initiative and a founding board member of the Institute for Diversity. His work has led to an increase in the number and influence of minority physicians and healthcare executives in the U.S, as well as improving overall health of people and communities.

He has been recognized 15 times by Modern Healthcare as one of the industry’s 100 Most Influential People. And in 2015, he was awarded the Gold Medal Award by the American College of Healthcare Executives, the highest honor the organization bestows on outstanding leaders who have made significant contributions to the healthcare profession.

"We are delighted to have Kevin Lofton join our Board of Directors," said Geoff Martha, Medtronic chief executive officer. "Kevin’s deep expertise in leading healthcare systems that serve a broad base of communities across the country will bring new perspectives and insight. His diverse experience, background, and expertise will be invaluable as we work to fulfill our Mission of alleviating pain, restoring health and extending life."

Mr. Lofton currently serves as the lead independent director of Gilead Sciences, and on the boards of Rite Aid Corporation and the Georgia State University Foundation.

About Medtronic
Medtronic plc (www.medtronic.com), headquartered in Dublin, Ireland, is among the world’s largest medical technology, services and solutions companies – alleviating pain, restoring health and extending life for millions of people around the world. Medtronic employs more than 90,000 people worldwide, serving physicians, hospitals and patients in more than 150 countries. The company is focused on collaborating with stakeholders around the world to take healthcare Further, Together.
Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.

-end-

EX-101.SCH 3 mdt-20200821.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0001001 - Document - Document And Entity Information link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 4 mdt-20200821_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 5 mdt-20200821_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 6 mdt-20200821_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity Address, City or Town Entity Address, City or Town 0.000% Senior Notes due 2021 Senior Notes 2019 Due 2021 [Member] Senior Notes 2019 Due 2021 [Member] Entities [Table] Entities [Table] 1.50% Senior Notes due 2039 Senior Notes 2019 Due 2039, 1.50 Percent [Member] Senior Notes 2019 Due 2039, 1.50 Percent [Member] Soliciting Material Soliciting Material Entity Address, Address Line One Entity Address, Address Line One Security Exchange Name Security Exchange Name City Area Code City Area Code Cover page. Cover [Abstract] Entity Central Index Key Entity Central Index Key Entity Tax Identification Number Entity Tax Identification Number Entity File Number Entity File Number Document Type Document Type 0.375% Senior Notes due 2023 Senior Notes 2019 Due 2023, 0.375 Percent [Member] Senior Notes 2019 Due 2023, 0.375 Percent [Member] Entity Emerging Growth Company Entity Emerging Growth Company 1.75% Senior Notes due 2049 Senior Notes 2019 Due 2049 [Member] Senior Notes 2019 Due 2049 [Member] Title of 12(b) Security Title of 12(b) Security Amendment Flag Amendment Flag Trading Symbol Trading Symbol Floating Rate Notes due 2021 Senior Notes 2019 Due 2021, Floating [Member] Senior Notes 2019 Due 2021, Floating [Member] Document Period End Date Document Period End Date Entity Information [Line Items] Entity Information [Line Items] Entity Registrant Name Entity Registrant Name Written Communications Written Communications Pre-commencement Tender Offer Pre-commencement Tender Offer Ordinary shares, par value $0.0001 per share Common Stock [Member] Class of Stock [Axis] Class of Stock [Axis] 0.25% Senior Notes due 2025 Senior Notes 2019 Due 2025 [Member] Senior Notes 2019 Due 2025 [Member] Entity Address, Country Entity Address, Country 1.00% Senior Notes due 2031 Senior Notes 2019 Due 2031, 1.00 Percent [Member] Senior Notes 2019 Due 2031, 1.00 Percent [Member] 1.625% Senior Notes due 2031 Senior Notes 2019 Due 2031, 1.625 Percent [Member] Senior Notes 2019 Due 2031, 1.625 Percent [Member] Local Phone Number Local Phone Number 2.250% Senior Notes due 2039 Senior Notes 2019 Due 2039, 2.250 Percent [Member] Senior Notes 2019 Due 2039, 2.250 Percent [Member] Entity Address, Postal Zip Code Entity Address, Postal Zip Code 0.000% Senior Notes due 2022 Senior Notes 2019 Due 2022 [Member] Senior Notes 2019 Due 2022 [Member] Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Class of Stock [Domain] Class of Stock [Domain] 1.125% Senior Notes due 2027 Senior Notes 2019 Due 2027 [Member] Senior Notes 2019 Due 2027 [Member] Country Region Country Region EX-101.PRE 7 mdt-20200821_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 8 image011.jpg MDT LOGO begin 644 image011.jpg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end XML 9 mdt-20200821_htm.xml IDEA: XBRL DOCUMENT 0001613103 2020-08-21 2020-08-21 0001613103 us-gaap:CommonStockMember 2020-08-21 2020-08-21 0001613103 mdt:SeniorNotes2019Due2021FloatingMember 2020-08-21 2020-08-21 0001613103 mdt:SeniorNotes2019Due2021Member 2020-08-21 2020-08-21 0001613103 mdt:SeniorNotes2019Due2022Member 2020-08-21 2020-08-21 0001613103 mdt:SeniorNotes2019Due20230.375PercentMember 2020-08-21 2020-08-21 0001613103 mdt:SeniorNotes2019Due2025Member 2020-08-21 2020-08-21 0001613103 mdt:SeniorNotes2019Due2027Member 2020-08-21 2020-08-21 0001613103 mdt:SeniorNotes2019Due20311.625PercentMember 2020-08-21 2020-08-21 0001613103 mdt:SeniorNotes2019Due20311.00PercentMember 2020-08-21 2020-08-21 0001613103 mdt:SeniorNotes2019Due20392.250PercentMember 2020-08-21 2020-08-21 0001613103 mdt:SeniorNotes2019Due20391.50PercentMember 2020-08-21 2020-08-21 0001613103 mdt:SeniorNotes2019Due2049Member 2020-08-21 2020-08-21 0001613103 Medtronic plc D02 XH02 false 8-K 2020-08-21 L2 1-36820 98-1183488 20 On Hatch, Lower Hatch Street Dublin 2 IE 353 1 438-1700 false false false false Ordinary shares, par value $0.0001 per share MDT NYSE Floating Rate Notes due 2021 MDT/21 NYSE 0.000% Senior Notes due 2021 MDT/21A NYSE 0.000% Senior Notes due 2022 MDT/22B NYSE 0.375% Senior Notes due 2023 MDT/23B NYSE 0.25% Senior Notes due 2025 MDT/25 NYSE 1.125% Senior Notes due 2027 MDT/27 NYSE 1.625% Senior Notes due 2031 MDT/31 NYSE 1.00% Senior Notes due 2031 MDT/31A NYSE 2.250% Senior Notes due 2039 MDT/39A NYSE 1.50% Senior Notes due 2039 MDT/39B NYSE 1.75% Senior Notes due 2049 MDT/49 NYSE false XML 10 R1.htm IDEA: XBRL DOCUMENT v3.20.2
Document And Entity Information
Aug. 21, 2020
Entity Information [Line Items]  
Document Type 8-K
Document Period End Date Aug. 21, 2020
Entity Registrant Name Medtronic plc
Entity Incorporation, State or Country Code L2
Entity File Number 1-36820
Entity Tax Identification Number 98-1183488
Entity Address, Address Line One 20 On Hatch, Lower Hatch Street
Entity Address, City or Town Dublin 2
Entity Address, Country IE
Entity Address, Postal Zip Code D02 XH02
Country Region 353
City Area Code 1
Local Phone Number 438-1700
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company false
Amendment Flag false
Entity Central Index Key 0001613103
Ordinary shares, par value $0.0001 per share  
Entity Information [Line Items]  
Title of 12(b) Security Ordinary shares, par value $0.0001 per share
Trading Symbol MDT
Security Exchange Name NYSE
Floating Rate Notes due 2021  
Entity Information [Line Items]  
Title of 12(b) Security Floating Rate Notes due 2021
Trading Symbol MDT/21
Security Exchange Name NYSE
0.000% Senior Notes due 2021  
Entity Information [Line Items]  
Title of 12(b) Security 0.000% Senior Notes due 2021
Trading Symbol MDT/21A
Security Exchange Name NYSE
0.000% Senior Notes due 2022  
Entity Information [Line Items]  
Title of 12(b) Security 0.000% Senior Notes due 2022
Trading Symbol MDT/22B
Security Exchange Name NYSE
0.375% Senior Notes due 2023  
Entity Information [Line Items]  
Title of 12(b) Security 0.375% Senior Notes due 2023
Trading Symbol MDT/23B
Security Exchange Name NYSE
0.25% Senior Notes due 2025  
Entity Information [Line Items]  
Title of 12(b) Security 0.25% Senior Notes due 2025
Trading Symbol MDT/25
Security Exchange Name NYSE
1.125% Senior Notes due 2027  
Entity Information [Line Items]  
Title of 12(b) Security 1.125% Senior Notes due 2027
Trading Symbol MDT/27
Security Exchange Name NYSE
1.625% Senior Notes due 2031  
Entity Information [Line Items]  
Title of 12(b) Security 1.625% Senior Notes due 2031
Trading Symbol MDT/31
Security Exchange Name NYSE
1.00% Senior Notes due 2031  
Entity Information [Line Items]  
Title of 12(b) Security 1.00% Senior Notes due 2031
Trading Symbol MDT/31A
Security Exchange Name NYSE
2.250% Senior Notes due 2039  
Entity Information [Line Items]  
Title of 12(b) Security 2.250% Senior Notes due 2039
Trading Symbol MDT/39A
Security Exchange Name NYSE
1.50% Senior Notes due 2039  
Entity Information [Line Items]  
Title of 12(b) Security 1.50% Senior Notes due 2039
Trading Symbol MDT/39B
Security Exchange Name NYSE
1.75% Senior Notes due 2049  
Entity Information [Line Items]  
Title of 12(b) Security 1.75% Senior Notes due 2049
Trading Symbol MDT/49
Security Exchange Name NYSE

EXCEL 11 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 12 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 13 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 14 FilingSummary.xml IDEA: XBRL DOCUMENT 3.20.2 html 13 96 1 false 12 0 false 0 false false R1.htm 0001001 - Document - Document And Entity Information Sheet http://www.medtronic.com/role/DocumentAndEntityInformation Document And Entity Information Cover 1 false false All Reports Book All Reports mdt-20200821.htm mdt-20200821.xsd mdt-20200821_cal.xml mdt-20200821_def.xml mdt-20200821_lab.xml mdt-20200821_pre.xml pressrelease8242020.htm http://xbrl.sec.gov/dei/2019-01-31 http://fasb.org/us-gaap/2019-01-31 true true JSON 17 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "mdt-20200821.htm": { "axisCustom": 0, "axisStandard": 1, "contextCount": 13, "dts": { "calculationLink": { "local": [ "mdt-20200821_cal.xml" ] }, "definitionLink": { "local": [ "mdt-20200821_def.xml" ], "remote": [ "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-eedm-def-2019-01-31.xml", "http://xbrl.fasb.org/srt/2019/elts/srt-eedm1-def-2019-01-31.xml" ] }, "inline": { "local": [ "mdt-20200821.htm" ] }, "labelLink": { "local": [ "mdt-20200821_lab.xml" ], "remote": [ "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml" ] }, "presentationLink": { "local": [ "mdt-20200821_pre.xml" ] }, "referenceLink": { "remote": [ "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml" ] }, "schema": { "local": [ "mdt-20200821.xsd" ], "remote": [ "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-roles-2019-01-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-roles-2019-01-31.xsd", "https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd", "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd" ] } }, "elementCount": 40, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2019-01-31": 4, "total": 4 }, "keyCustom": 0, "keyStandard": 96, "memberCustom": 11, "memberStandard": 1, "nsprefix": "mdt", "nsuri": "http://www.medtronic.com/20200821", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "mdt-20200821.htm", "contextRef": "i6fd05f9efcd247f7a0b82e9cf7e065f9_D20200821-20200821", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0001001 - Document - Document And Entity Information", "role": "http://www.medtronic.com/role/DocumentAndEntityInformation", "shortName": "Document And Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "mdt-20200821.htm", "contextRef": "i6fd05f9efcd247f7a0b82e9cf7e065f9_D20200821-20200821", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 12, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Region code of country", "label": "Country Region", "terseLabel": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover page." } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntitiesTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Container to assemble all relevant information about each entity associated with the document instance", "label": "Entities [Table]", "terseLabel": "Entities [Table]" } } }, "localname": "EntitiesTable", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country", "terseLabel": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInformationLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Entity Information [Line Items]", "terseLabel": "Entity Information [Line Items]" } } }, "localname": "EntityInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer", "terseLabel": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer", "terseLabel": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-US": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-US": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "mdt_SeniorNotes2019Due2021FloatingMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Senior Notes 2019 Due 2021, Floating [Member]", "label": "Senior Notes 2019 Due 2021, Floating [Member]", "terseLabel": "Floating Rate Notes due 2021" } } }, "localname": "SeniorNotes2019Due2021FloatingMember", "nsuri": "http://www.medtronic.com/20200821", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "mdt_SeniorNotes2019Due2021Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Senior Notes 2019 Due 2021 [Member]", "label": "Senior Notes 2019 Due 2021 [Member]", "terseLabel": "0.000% Senior Notes due 2021" } } }, "localname": "SeniorNotes2019Due2021Member", "nsuri": "http://www.medtronic.com/20200821", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "mdt_SeniorNotes2019Due2022Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Senior Notes 2019 Due 2022 [Member]", "label": "Senior Notes 2019 Due 2022 [Member]", "terseLabel": "0.000% Senior Notes due 2022" } } }, "localname": "SeniorNotes2019Due2022Member", "nsuri": "http://www.medtronic.com/20200821", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "mdt_SeniorNotes2019Due20230.375PercentMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Senior Notes 2019 Due 2023, 0.375 Percent [Member]", "label": "Senior Notes 2019 Due 2023, 0.375 Percent [Member]", "terseLabel": "0.375% Senior Notes due 2023" } } }, "localname": "SeniorNotes2019Due20230.375PercentMember", "nsuri": "http://www.medtronic.com/20200821", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "mdt_SeniorNotes2019Due2025Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Senior Notes 2019 Due 2025 [Member]", "label": "Senior Notes 2019 Due 2025 [Member]", "terseLabel": "0.25% Senior Notes due 2025" } } }, "localname": "SeniorNotes2019Due2025Member", "nsuri": "http://www.medtronic.com/20200821", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "mdt_SeniorNotes2019Due2027Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Senior Notes 2019 Due 2027 [Member]", "label": "Senior Notes 2019 Due 2027 [Member]", "terseLabel": "1.125% Senior Notes due 2027" } } }, "localname": "SeniorNotes2019Due2027Member", "nsuri": "http://www.medtronic.com/20200821", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "mdt_SeniorNotes2019Due20311.00PercentMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Senior Notes 2019 Due 2031, 1.00 Percent [Member]", "label": "Senior Notes 2019 Due 2031, 1.00 Percent [Member]", "terseLabel": "1.00% Senior Notes due 2031" } } }, "localname": "SeniorNotes2019Due20311.00PercentMember", "nsuri": "http://www.medtronic.com/20200821", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "mdt_SeniorNotes2019Due20311.625PercentMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Senior Notes 2019 Due 2031, 1.625 Percent [Member]", "label": "Senior Notes 2019 Due 2031, 1.625 Percent [Member]", "terseLabel": "1.625% Senior Notes due 2031" } } }, "localname": "SeniorNotes2019Due20311.625PercentMember", "nsuri": "http://www.medtronic.com/20200821", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "mdt_SeniorNotes2019Due20391.50PercentMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Senior Notes 2019 Due 2039, 1.50 Percent [Member]", "label": "Senior Notes 2019 Due 2039, 1.50 Percent [Member]", "terseLabel": "1.50% Senior Notes due 2039" } } }, "localname": "SeniorNotes2019Due20391.50PercentMember", "nsuri": "http://www.medtronic.com/20200821", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "mdt_SeniorNotes2019Due20392.250PercentMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Senior Notes 2019 Due 2039, 2.250 Percent [Member]", "label": "Senior Notes 2019 Due 2039, 2.250 Percent [Member]", "terseLabel": "2.250% Senior Notes due 2039" } } }, "localname": "SeniorNotes2019Due20392.250PercentMember", "nsuri": "http://www.medtronic.com/20200821", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "mdt_SeniorNotes2019Due2049Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Senior Notes 2019 Due 2049 [Member]", "label": "Senior Notes 2019 Due 2049 [Member]", "terseLabel": "1.75% Senior Notes due 2049" } } }, "localname": "SeniorNotes2019Due2049Member", "nsuri": "http://www.medtronic.com/20200821", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Class of Stock [Domain]", "terseLabel": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Common Stock [Member]", "terseLabel": "Ordinary shares, par value $0.0001 per share" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Class of Stock [Axis]", "terseLabel": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "xbrltype": "stringItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } ZIP 18 0001613103-20-000024-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001613103-20-000024-xbrl.zip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